Terms: = Colorectal cancer AND ATIC, IMPCHASE, 471, ENSG00000138363, AICARFT, P31939, PURH AND Treatment
57 results:
1. Comparing the use of aggressive end-of life care among frail and non-frail patients with cancer using a claims-based frailty index.
Sachdev R; Shearn-Nance G; Vu L; Bensken WP; Douglas SL; Koroukian SM; Rose J
J Geriatr Oncol; 2024 Mar; 15(2):101706. PubMed ID: 38320468
[TBL] [Abstract] [Full Text] [Related]
2. [High expression of secretogranin II increases oxaliplatin resistance of colorectal cancer cells].
Deng J; Pan T; Zhou G; Gao Y; Peng W; Wei W; Lü C
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1657-1664. PubMed ID: 37933640
[TBL] [Abstract] [Full Text] [Related]
3. Pain and its interference with daily living in relation to cancer: a comparative population-based study of 16,053 cancer survivors and 106,345 people without cancer.
Joshy G; Khalatbari-Soltani S; Soga K; Butow P; Laidsaar-Powell R; Koczwara B; Rankin NM; Brown S; Weber M; Mazariego C; Grogan P; Stubbs J; Thottunkal S; Canfell K; Blyth FM; Banks E
BMC Cancer; 2023 Sep; 23(1):774. PubMed ID: 37700229
[TBL] [Abstract] [Full Text] [Related]
4. Weight Loss During Neoadjuvant Therapy Is Associated With Poor Response Among the Patients With Gastrointestinal cancer: A Propensity Score Matching Analysis.
Bu Z; Jiang Y; Luo S; He X; Qin H; Tang W
Cancer Control; 2023; 30():10732748231164016. PubMed ID: 37071968
[TBL] [Abstract] [Full Text] [Related]
5. Association of distance traveled on receipt of surgery in patients with locally advanced rectal cancer.
Hao S; Meyer D; Klose C; Irish W; Honaker MD
Int J Colorectal Dis; 2023 Jan; 38(1):8. PubMed ID: 36629973
[TBL] [Abstract] [Full Text] [Related]
6. [Efficacy of endoscopic treatment oncolorectal laterally spreading tumor and risk factors of delayed bleeding after operation].
Yu QY; Xue M; Wang LJ
Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(46):3680-3685. PubMed ID: 36509539
[No Abstract] [Full Text] [Related]
7. Simultaneous versus staged resection for synchronous colorectal liver metastases: The win ratio approach.
Endo Y; Alaimo L; Araujo Lima H; Tsilimigras DI; Hyer JM; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
Am J Surg; 2023 Mar; 225(3):461-465. PubMed ID: 36435656
[TBL] [Abstract] [Full Text] [Related]
8. Follow-up strategy and survival for five common cancers: A meta-analysis.
Galjart B; Höppener DJ; Aerts JGJV; Bangma CH; Verhoef C; Grünhagen DJ
Eur J Cancer; 2022 Oct; 174():185-199. PubMed ID: 36037595
[TBL] [Abstract] [Full Text] [Related]
9. Disparities in Survival and Comorbidity Burden Between Asian and Native Hawaiian and Other Pacific Islander Patients With cancer.
Taparra K; Qu V; Pollom E
JAMA Netw Open; 2022 Aug; 5(8):e2226327. PubMed ID: 35960520
[TBL] [Abstract] [Full Text] [Related]
10. Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic cancers.
Noh JJ; Kim MK; Choi MC; Lee JW; Park H; Jung SG; Joo WD; Song SH; Lee C
Cancer Res Treat; 2022 Oct; 54(4):1200-1208. PubMed ID: 34902958
[TBL] [Abstract] [Full Text] [Related]
11. Local control of bone metastases treated with external beam radiotherapy in recent years: a multicenter retrospective study.
Makita K; Hamamoto Y; Kanzaki H; Kataoka M; Yamamoto S; Nagasaki K; Ishikawa H; Takata N; Tsuruoka S; Uwatsu K; Kido T
Radiat Oncol; 2021 Nov; 16(1):225. PubMed ID: 34801042
[TBL] [Abstract] [Full Text] [Related]
12. Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations.
Mili N; Paschou SA; Goulis DG; Dimopoulos MA; Lambrinoudaki I; Psaltopoulou T
Endocrine; 2021 Dec; 74(3):478-497. PubMed ID: 34625915
[TBL] [Abstract] [Full Text] [Related]
13. Patterns and resectability of colorectal cancer recurrences: outcome study within the COLOFOL trial.
Hansdotter P; Scherman P; Petersen SH; Mikalonis M; Holmberg E; Rizell M; Naredi P; Syk I
BJS Open; 2021 Jul; 5(4):. PubMed ID: 34308474
[TBL] [Abstract] [Full Text] [Related]
14. Clinical characteristics and outcomes of incidental venous thromboembolism in cancer patients: Insights from the Caravaggio study.
Giustozzi M; Connors JM; Ruperez Blanco AB; Szmit S; Falvo N; Cohen AT; Huisman M; Bauersachs R; Dentali F; Becattini C; Agnelli G
J Thromb Haemost; 2021 Nov; 19(11):2751-2759. PubMed ID: 34260816
[TBL] [Abstract] [Full Text] [Related]
15. Predictors of clinical outcomes of self-expandable metal stent treatment for malignant colorectal obstruction: A Honam Association for the Study of Intestinal Disease (HASID) multicenter study.
Han B; Hong JY; Myung E; Oh HH; Yang HC; Kim SW; Lee J; Kim SJ; Han YD; Seo GS; Hong GY; Kim HD; Kim HS; Joo YE
Medicine (Baltimore); 2021 Jul; 100(27):e26616. PubMed ID: 34232219
[TBL] [Abstract] [Full Text] [Related]
16. General Health Checks in Adult Primary Care: A Review.
Liss DT; Uchida T; Wilkes CL; Radakrishnan A; Linder JA
JAMA; 2021 Jun; 325(22):2294-2306. PubMed ID: 34100866
[TBL] [Abstract] [Full Text] [Related]
17. colorectal cancer patients with malnutrition suffer poor physical and mental health before surgery.
Gillis C; Richer L; Fenton TR; Gramlich L; Keller H; Culos-Reed SN; Sajobi TT; Awasthi R; Carli F
Surgery; 2021 Sep; 170(3):841-847. PubMed ID: 33966805
[TBL] [Abstract] [Full Text] [Related]
18. Randomised phase II trial of capecitabine plus oxaliplatin with continuous versus intermittent use of oxaliplatin as adjuvant chemotherapy for stage II/III colon cancer (CCOG-1302 study).
Nakayama G; Takano N; Taniguchi H; Ishigure K; Yokoyama H; Teramoto H; Hashimoto R; Sakai M; Ishiyama A; Kinoshita T; Hayashi N; Nakamura M; Hattori N; Sato Y; Umeda S; Uehara K; Aiba T; Sonohara F; Hayashi M; Kanda M; Kobayashi D; Tanaka C; Yamada S; Koike M; Fujiwara M; Murotani K; Ando M; Ando Y; Muro K; Kodera Y
Eur J Cancer; 2021 Feb; 144():61-71. PubMed ID: 33340853
[TBL] [Abstract] [Full Text] [Related]
19. Primary Squamous Cell Carcinoma of Colon and Rectum: A Systematic Review of the Literature.
Schizas D; Katsaros I; Mastoraki A; Karela NR; Zampetaki D; Lazaridis II; Tsapralis D; Theodoropoulos GE
J Invest Surg; 2022 Jan; 35(1):151-156. PubMed ID: 33021125
[No Abstract] [Full Text] [Related]
20. Integrated proteomics and metabolomics reveals the comprehensive characterization of antitumor mechanism underlying Shikonin on colon cancer patient-derived xenograft model.
Chen Y; Ni J; Gao Y; Zhang J; Liu X; Chen Y; Chen Z; Wu Y
Sci Rep; 2020 Aug; 10(1):14092. PubMed ID: 32839531
[TBL] [Abstract] [Full Text] [Related]
[Next]
